MRI may reduce unnecessary biopsies for prostate cancer patients
NCT ID NCT04692675
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study looks at whether advanced MRI scans (mpMRI) can better track prostate cancer in men who choose active surveillance instead of immediate treatment. About 500 men with low-risk prostate cancer will have regular MRIs alongside standard tests like PSA blood tests and biopsies. The goal is to see if MRI can predict cancer progression more accurately, potentially reducing the number of invasive biopsies needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
multiparametric magnetic resonance imaging (mpMRI)
What this could lead to
If successful, this could show that mpMRI helps doctors monitor prostate cancer more accurately during active surveillance, possibly reducing the need for frequent biopsies.
What could go wrong
This is an observational study, not a treatment trial. It may not change current practice, and results depend on how well imaging matches biopsy findings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.